UBS Group AG - NEUROSENSE THERAPEUTICS LTD ownership

NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240116. A total of 6 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NEUROSENSE THERAPEUTICS LTD
ValueSharesWeighting
Q3 2023$422
+229.7%
3,802
+376.4%
0.00%
Q4 2022$128798
-59.2%
0.00%
Q3 2022$0
-100.0%
1,958
-56.4%
0.00%
Q4 2021$4,0004,4910.00%
Other shareholders
NEUROSENSE THERAPEUTICS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Empery Asset Management, LP 160,000$82,0000.44%
Warberg Asset Management LLC 77,100$39,0000.01%
CLEAR STREET LLC 52,458$27,0000.00%
Hudson Bay Capital Management LP 150,000$81,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEUROSENSE THERAPEUTICS LTD shareholders